Editor's Special Episode: Future Directions in MPN Treatment with Dr. Hobbs
The HemOnc Pulse
00:00
SURPASS‑ET: Ropeginterferon vs anagrelide efficacy
Nicole introduces SURPASS‑ET and Dr. Hobbs details superior blood count control, symptom benefits, and JAK2 allele reductions with ropeginterferon.
Play episode from 06:08
Transcript
